{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Schaumburg",
      "state": "IL",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "70600",
      "recalling_firm": "Sagent Pharmaceuticals Inc",
      "address_1": "1901 N Roselle Rd Ste 700",
      "address_2": "N/A",
      "postal_code": "60195-3194",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide and Puerto Rico",
      "recall_number": "D-0399-2015",
      "product_description": "Atracurium Besylate Injection, USP, 100 mg per 10 mL (10 mg per mL), Rx Only, 10 mL Multi-Dose Vial, For Intravenous Injection, Mfd. for: Sagent Pharmaceuticals, Schaumberg, IL 60195, NDC 25021-672-10",
      "product_quantity": "140,850 vials",
      "reason_for_recall": "Lack of Assurance of Sterility: Recall initiated due to FDA observations pertaining to aseptic and GMP practices at the manufacturers site potentially impacting product sterility.",
      "recall_initiation_date": "20150223",
      "center_classification_date": "20150303",
      "termination_date": "20160622",
      "report_date": "20150311",
      "code_info": "Lot Numbers: VATB012, VATB013, VATB014, Exp 11/15; VATB017, Exp 08/16"
    }
  ]
}